Targeted degradation of SETDB1 by an Aptamer-CRBNL PROTAC as a novel therapeutic strategy for breast cancer

European Journal of Medicinal Chemistry 2026

View at publisher

Authors: Shuyu Huang, Yingge Lv, Yuting Wang, Yang Duan, Shujie Li, Yanxuan Guo, Songbo Xie, Cheng Dong, Yang Yang, 孙绍凯, Chenghao Xuan

DOI: 10.1016/j.ejmech.2026.118982

Cited by: 1

References: 41

Fields of Study & Subjects

Protein Degradation and Inhibitors Advanced Breast Cancer Therapies Histone Deacetylase Inhibitors Research

References 41